Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 1,935 | 112,089 | 9,266 | 5,634 | 8,093 |
| Gross Profit | 1,935 | 112,089 | 9,266 | 5,634 | 8,093 |
| Operating Expenses | 25,496 | 33,799 | 26,286 | 31,518 | 38,094 |
| Operating Income | -23,561 | 78,290 | -17,020 | -25,884 | -30,001 |
| Other Income | 260 | 364 | 379 | 634 | 957 |
| Pre-tax Income | -23,301 | 78,654 | -16,641 | -25,250 | -29,044 |
| Income Tax | N/A | -255 | -132 | -182 | -122 |
| Net Income Continuous | -23,301 | 78,909 | -16,509 | -25,068 | -28,922 |
| Net Income | $-23,301 | $78,909 | $-16,509 | $-25,068 | $-28,922 |
| EPS Basic Total Ops | -16.93 | 60.87 | -12.61 | -19.45 | -22.33 |
| EPS Basic Continuous Ops | -16.81 | 60.66 | -12.68 | -19.29 | -22.29 |
| EPS Diluted Total Ops | -16.93 | 60.87 | -12.61 | -19.45 | -22.33 |
| EPS Diluted Continuous Ops | -16.81 | 60.59 | -12.68 | -19.29 | -22.29 |
| EBITDA(a) | $-22,988 | $78,788 | $-16,736 | $-25,640 | $-29,858 |